Skip to main content

Biomedical Translational Research

From Disease Diagnosis to Treatment

  • Book
  • © 2022

Overview

  • Evaluates application of clinical genomics, molecule-based approaches for disease diagnosis

  • Examines novel strategies for the diagnosis and treatment of cancer

  • Analyzes the importance of genetic and genomic studies on tailored treatment strategies

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (24 chapters)

Keywords

About this book

The second volume of the Biomedical translational research discusses advancements in biomedical research for understanding the pathophysiology of various diseases towards improving diagnosis and treatment. It presents the integration of molecular-based technologies, clinical genomics, and medical informatics to improve diagnostic and treatment strategies. Further, the book reviews molecular genomics approaches for diagnosis and managing tuberculosis. It also covers the innovative strategies for cancer treatment through targeting metabolic pathways, tumor microenvironment, cancer stem cells, and immune cells.  It also illuminates novel strategies for heart failure diagnosis and therapeutic approaches for the treatment of heart failure. It discusses improvements in translational research for discovery of new diagnostic tests, identifying novel biomarkers and drugable targets, and predicting optimal treatments based on understanding the underlying molecular basis of the disease. Lastly, it reviews the preclinical models of restenosis and their application and limitation in the evaluation of device-based interventional technologies for the treatment of coronary artery diseases.

Editors and Affiliations

  • Department of Biotechnology, Punjab University, Chandigarh, India

    R.C. Sobti

  • Department of Pathology, University of Miami Health System, Florida, USA

    Awtar Krishan Ganju

About the editors

Professor Ranbir Chander Sobti is an Emeritus Professor and Indian National Science Academy (INSA) senior scientist at Punjab University. He is a former Vice-Chancellor of the Panjab University, Chandigarh & Babasaheb Bhimrao Ambedkar University (Central University), Lucknow. He started his career as a cytogeneticist and then moved on to molecular biology, including genomics, to understand the susceptibility and disease process of cancer, COPD, AIDS metabolic syndrome, and kidney diseases. He has also used stem cells and nanoparticles to understand the process of tissue organ development through a designed de-cellularization protocol.  He has published more than 300 research articles in the journals of international repute and has also published more than 40 books.

He is a Fellow of the Third World Academy of Sciences, National Academy of Sciences India, Indian National Science Academy, National Academy of Medical Sciences, National Academy of Agricultural Sciences, Canadian Academy of Cardiovascular Diseases and few others. He was the General President of the Indian Science Congress for the 102nd session held at the University of Jammu in 2013. Dr. Sobti is the recipient of many prestigious awards like the INSA Young Scientist Medal, UGC Career Award, Punjab Rattan Award, JC Bose Oration and Sriram Oration Awards and of Life Time Achievement Awards of the Punjab Academy of Sciences, Zoological Society of India, and the Environment Academy of India.

Dr Awtar Krishan Ganju had been Scientific Director of Comprehensive Cancer, University of Miami Medical School. Now is Emeritus Professor, Department of Pathology in the University of Miami, Medical School, Miami. He is a renowned cancer biologist and has been one of the pioneer in the flow cytometry, cancer diagnosis and drug development. He has published a large number of papers in the international journals of repute. He is widely travelled and has trained faculty and students in flow cytometry technology world over. 

Bibliographic Information

  • Book Title: Biomedical Translational Research

  • Book Subtitle: From Disease Diagnosis to Treatment

  • Editors: R.C. Sobti, Awtar Krishan Ganju

  • DOI: https://doi.org/10.1007/978-981-16-8845-4

  • Publisher: Springer Singapore

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2022

  • Hardcover ISBN: 978-981-16-8844-7Published: 15 June 2022

  • Softcover ISBN: 978-981-16-8847-8Published: 16 June 2023

  • eBook ISBN: 978-981-16-8845-4Published: 14 June 2022

  • Edition Number: 1

  • Number of Pages: XIV, 491

  • Number of Illustrations: 1 b/w illustrations

  • Topics: Biomedicine, general, Medicine/Public Health, general, Biochemistry, general, Cancer Research

Publish with us